B. burgdorferi Hematogenous Dissemination

伯氏疏螺旋体的血行传播

基本信息

  • 批准号:
    7913572
  • 负责人:
  • 金额:
    $ 17.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-17 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Lyme disease, the most prevalent arthropod-borne disease in the United States, is caused by infection with the spirochete, Borrelia burgdorferi. Despite intensive study in recent years little is known regarding the pathogenesis of infection at the molecular level. We have determined the genetic diversity among clinical isolates of B. burgdorferi and shown that spirochete dissemination varies significantly in patients and mice infected with distinct genotypes. These results demonstrate that different genotypes of B. burgdorferi possess varying potential for dissemination in an infected host. We hypothesize that these differences are the result of variations in gene content and/or expression among different genotypes. We propose to employ functional genomics and proteomics to gain insight into possible differences in gene/protein expression between B. burgdorferi strains with differing capacities for hematogenous dissemination. The long-term objective of this project is elucidation of genes and/or proteins that mediate B. burgdorferi virulence. The following specific aims are proposed: 1) global gene expression of B. burgdorferi clinical isolates of differing genotype in varying environments will be monitored by gene array; 2) differences in protein expression among the various genotypes will be assessed by proteomics; 3) the roles of candidate virulence genes in pathogenesis of Lyme disease will be evaluated by monitoring expression for a number of the most promising candidate genes will be monitored in early Lyme disease patients and infected mice by real-time RT-PCR; 4) selected candidate virulence genes will then be targeted for insertional inactivation and complementation. The effects of such genetic manipulation should provide direct demonstration of the critical role such genes may play in spirochete pathogenesis. \The combination of functional genomics, in vivo and genetic approaches proposed here should provide for the comprehensive assessment of the molecular basis of pathogenesis for B. burgdorferi isolates with varying potential for bloodstream dissemination and result in identification of determinants required for spirochete dissemination. This will provide new insights into the natural history of B. burgdorferi infection in humans, which, in turn, may have implications for prevention, treatment, and diagnosis of Lyme disease.
描述(由申请人提供):莱姆病是美国最流行的节肢动物传播疾病,由螺旋体伯氏疏螺旋体感染引起。尽管近年来进行了深入的研究,但在分子水平上对感染的发病机制知之甚少。我们确定了B临床分离株的遗传多样性。Burgdorferi的研究表明,在感染不同基因型的患者和小鼠中,螺旋体的传播有显著差异。这些结果表明,不同基因型的B。伯氏螺旋体在受感染的宿主中具有不同的传播潜力。我们假设这些差异是不同基因型之间基因含量和/或表达变化的结果。我们建议采用功能基因组学和蛋白质组学来深入了解B之间基因/蛋白质表达的可能差异。具有不同的血行播散能力的伯氏菌株。该项目的长期目标是阐明介导B的基因和/或蛋白质。伯氏菌毒力提出了以下具体目标:1)B的全局基因表达。通过基因阵列监测不同环境中不同基因型的伯氏临床分离株; 2)通过蛋白质组学评估不同基因型之间蛋白质表达的差异; 3)候选毒力基因在莱姆病发病机制中的作用将通过监测许多最有希望的候选基因的表达来评估,这些候选基因将在早期莱姆病患者和感染小鼠中通过真实的-时间RT-PCR; 4)然后将选定的候选毒力基因靶向用于插入失活和互补。这种遗传操作的影响应该提供直接的证据,这些基因可能在螺旋体发病机制中发挥关键作用。 本文提出的功能基因组学、体内和遗传学方法相结合,将为全面评价B发病机制的分子基础提供依据。具有不同的血流传播潜力的伯氏螺旋体分离物,并鉴定螺旋体传播所需的决定因素。这将为B的自然历史提供新的见解。这反过来可能对莱姆病的预防、治疗和诊断有意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ira S. Schwartz其他文献

Interobserver reproducibility of histopathological features in stage II breast cancer
  • DOI:
    10.1007/bf01807642
  • 发表时间:
    1985-02-01
  • 期刊:
  • 影响因子:
    3.000
  • 作者:
    Kennedy W. Gilchrist;Leslie Kalish;Victor E. Gould;Simon Hirschl;Joseph E. Imbriglia;Walter M. Levy;Arthur S. Patchefsky;Donald W. Penner;John Pickren;Joel A. Roth;Roger A. Schinella;Ira S. Schwartz;James E. Wheeler
  • 通讯作者:
    James E. Wheeler
Fatal hemorrhage from a gastric cirsoid aneurysm
  • DOI:
    10.1016/s0046-8177(85)80236-7
  • 发表时间:
    1985-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Lawrence J. Finkel;Ira S. Schwartz
  • 通讯作者:
    Ira S. Schwartz
Immunostaining for carcinoembryonic antigen does not discriminate for early recurrence in breast cancer. The ECOG experience
癌胚抗原的免疫染色不能区分乳腺癌的早期复发。
  • DOI:
  • 发表时间:
    1985
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    K. Gilchrist;Leslie A. Kalish;V. Gould;S. Hirschl;J. Imbriglia;Walter M. Levy;A. Patchefsky;J. Pickren;J. A. Roth;R. Schinella;Ira S. Schwartz;J. Wheeler;D. Tormey
  • 通讯作者:
    D. Tormey
Malignant transformation in a plexiform neurofibroma of the median nerve
  • DOI:
    10.1016/s0363-5023(84)80116-1
  • 发表时间:
    1984-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    Geoffrey D. Williams;Saul Hoffman;Ira S. Schwartz
  • 通讯作者:
    Ira S. Schwartz

Ira S. Schwartz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ira S. Schwartz', 18)}}的其他基金

Gene Expression Biomarkers for Diagnosis of Lyme Disease
用于诊断莱姆病的基因表达生物标志物
  • 批准号:
    8063743
  • 财政年份:
    2010
  • 资助金额:
    $ 17.38万
  • 项目类别:
Gene Expression Biomarkers for Diagnosis of Lyme Disease
用于诊断莱姆病的基因表达生物标志物
  • 批准号:
    8324940
  • 财政年份:
    2010
  • 资助金额:
    $ 17.38万
  • 项目类别:
Gene Expression Biomarkers for Diagnosis of Lyme Disease
用于诊断莱姆病的基因表达生物标志物
  • 批准号:
    8138662
  • 财政年份:
    2010
  • 资助金额:
    $ 17.38万
  • 项目类别:
Genotypic variation and B. burgdorferi pathogenesis
基因型变异和伯氏疏螺旋体发病机制
  • 批准号:
    7814345
  • 财政年份:
    2009
  • 资助金额:
    $ 17.38万
  • 项目类别:
Lyme Disease Diagnosis with Host Gene Expression Arrays
使用宿主基因表达阵列诊断莱姆病
  • 批准号:
    7054042
  • 财政年份:
    2004
  • 资助金额:
    $ 17.38万
  • 项目类别:
Lyme Disease Diagnosis with Host Gene Expression Arrays
使用宿主基因表达阵列诊断莱姆病
  • 批准号:
    6881342
  • 财政年份:
    2004
  • 资助金额:
    $ 17.38万
  • 项目类别:
Lyme Disease Diagnosis with Host Gene Expression Arrays
使用宿主基因表达阵列诊断莱姆病
  • 批准号:
    7218694
  • 财政年份:
    2004
  • 资助金额:
    $ 17.38万
  • 项目类别:
Lyme Disease Diagnosis with Host Gene Expression Arrays
使用宿主基因表达阵列诊断莱姆病
  • 批准号:
    6829552
  • 财政年份:
    2004
  • 资助金额:
    $ 17.38万
  • 项目类别:
B. burgdorferi Hematogenous Dissemination
伯氏疏螺旋体的血行传播
  • 批准号:
    6913633
  • 财政年份:
    1999
  • 资助金额:
    $ 17.38万
  • 项目类别:
Borrelia burgdorferi tick phase genes and Lyme disease pathogenesis
伯氏疏螺旋体蜱期基因与莱姆病发病机制
  • 批准号:
    8389638
  • 财政年份:
    1999
  • 资助金额:
    $ 17.38万
  • 项目类别:

相似海外基金

Implication search for peripheral blood circulation cancer cellsas a Liquid biopsy target
外周血循环癌细胞作为液体活检目标的意义研究
  • 批准号:
    21H03021
  • 财政年份:
    2021
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Feasibility study to reach 'market readiness' with Recocoa's unique cacao based health bar, which is the only health nutrition bar which meets the European Health Claim (EFSA) in improving blood circulation by maintaining the elasticity of blood vessels.
Recocoa 独特的可可健康棒进行了“市场准备”的可行性研究,该健康棒是唯一符合欧洲健康声明 (EFSA) 通过保持血管弹性改善血液循环的健康营养棒。
  • 批准号:
    106360
  • 财政年份:
    2020
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Collaborative R&D
Feasibility study to reach 'market readiness' with Recocoa's unique cacao based health bar, which is the only health nutrition bar which meets the European Health Claim (EFSA) in improving blood circulation by maintaining the elasticity of blood vessels.
Recocoa 独特的可可健康棒进行了“市场准备”的可行性研究,该健康棒是唯一符合欧洲健康声明 (EFSA) 通过保持血管弹性改善血液循环的健康营养棒。
  • 批准号:
    72375
  • 财政年份:
    2020
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Feasibility Studies
Quantitative evaluation of blood circulation by deep learning in short time DCE-MRI
短时间深度学习DCE-MRI对血液循环的定量评估
  • 批准号:
    20K08041
  • 财政年份:
    2020
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Evaluation of the micro blood circulation of the oral free flaps by indocyanin green near-infrared fluorescence angiography
吲哚青绿近红外荧光血管造影评价口腔游离皮瓣的微血循环
  • 批准号:
    19K10299
  • 财政年份:
    2019
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of a new treatment for pancreatic cancer by controlling immune response avoidance of blood circulation cancer stem cells
通过控制血液循环癌症干细胞的免疫反应避免建立胰腺癌新疗法
  • 批准号:
    19K09139
  • 财政年份:
    2019
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of ICG fluorescence contrast imaging analysis system specialized for evaluation of peripheral tissue blood circulation
开发专门评估末梢组织血液循环的ICG荧光对比成像分析系统
  • 批准号:
    19K18925
  • 财政年份:
    2019
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Hemopurifier Device for Targeted Removal of Breast Cancer Exosomes from the Blood Circulation
用于从血液循环中靶向去除乳腺癌外泌体的血液净化器装置
  • 批准号:
    9620493
  • 财政年份:
    2018
  • 资助金额:
    $ 17.38万
  • 项目类别:
Development of the small blood circulation simulator to deepen the non-clinical evaluation of medical devices
开发小型血液循环模拟器深化医疗器械非临床评价
  • 批准号:
    18H03555
  • 财政年份:
    2018
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Experimental analysis of conservative therapy for blood circulation disorders using multifaceted optical measurement of nerve activity and peripheral blood flow
多层面光学测量神经活动和外周血流量保守治疗血液循环障碍的实验分析
  • 批准号:
    17K10764
  • 财政年份:
    2017
  • 资助金额:
    $ 17.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了